Eiger BioPharmaceuticals, Inc. (EIGRQ)
USD 8.5
(6.25%)
USD 8.5
(6.25%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 15.76 Million USD | 9.46% |
| 2022 | 14.4 Million USD | 39.57% |
| 2021 | 10.31 Million USD | 182.68% |
| 2020 | 3.65 Million USD | 151.2% |
| 2019 | -7.12 Million USD | 80.0% |
| 2018 | -35.64 Million USD | -110.38% |
| 2017 | -16.94 Million USD | -30.03% |
| 2016 | -13.02 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | 25.24 Million USD | 75.29% |
| 2023 Q2 | 17.68 Million USD | -29.93% |
| 2023 FY | 15.76 Million USD | 9.46% |
| 2023 Q3 | 13.43 Million USD | -24.03% |
| 2023 Q4 | 15.76 Million USD | 17.3% |
| 2022 Q3 | 13.28 Million USD | 377.4% |
| 2022 Q1 | -13.97 Million USD | -235.42% |
| 2022 FY | 14.4 Million USD | 39.57% |
| 2022 Q4 | 14.4 Million USD | 8.39% |
| 2022 Q2 | 2.78 Million USD | 119.92% |
| 2021 Q2 | -32.62 Million USD | 0.0% |
| 2021 FY | 10.31 Million USD | 182.68% |
| 2021 Q4 | 10.31 Million USD | 161.51% |
| 2021 Q3 | -16.77 Million USD | 48.59% |
| 2020 FY | 3.65 Million USD | 151.2% |
| 2019 FY | -7.12 Million USD | 80.0% |
| 2018 FY | -35.64 Million USD | -110.38% |
| 2017 FY | -16.94 Million USD | -30.03% |
| 2016 FY | -13.02 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | 1203382.443% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -179.072% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 63.165% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 6414.798% |
| Rebus Holdings, Inc. | 305 Thousand USD | -5068.197% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 350.027% |
| Qrons Inc. | 351.42 Thousand USD | -4385.427% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -2432.762% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 63.708% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 77339.318% |
| Skye Bioscience, Inc. | -5.72 Million USD | 375.51% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -282.781% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -3822.618% |
| SQZ Biotechnologies Company | -36.23 Million USD | 143.499% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -603.005% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -1600.09% |
| Mesoblast Limited | 55.85 Million USD | 71.78% |
| Marizyme, Inc. | 18.56 Million USD | 15.111% |
| Genus plc | 190.6 Million USD | 91.73% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -605.017% |
| Pharming Group N.V. | 109.8 Million USD | 85.644% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -1732.393% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -1198.555% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -2218.088% |
| ContraFect Corporation | -6.02 Million USD | 361.583% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -11607.603% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -1264.255% |
| IMV Inc. | 7.67 Million USD | -105.501% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -186.501% |
| MultiCell Technologies, Inc. | 90.04 USD | -17506563.705% |
| ONE Bio Corp. | 9.04 Million USD | -74.369% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 2247.612% |
| RVL Pharmaceuticals plc | 12.94 Million USD | -21.76% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | -1052.291% |
| Q BioMed Inc. | 4.06 Million USD | -288.25% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 48.409% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -1464.23% |
| Biomind Labs Inc. | 711.4 Thousand USD | -2115.765% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 73.965% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -688.39% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | -23.085% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -4282.141% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -11175.071% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -79242.628% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -615.855% |
| GB Sciences, Inc. | 1.74 Million USD | -802.126% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 8676.73% |
| HST Global, Inc. | 96.79 Thousand USD | -16185.269% |
| CSL Limited | 10.52 Billion USD | 99.85% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -7543.89% |
| Halberd Corporation | 144.72 Thousand USD | -10791.992% |
| Enzolytics Inc. | 981.65 Thousand USD | -1505.756% |
| Agentix Corp. | 37.63 Thousand USD | -41788.337% |
| Resverlogix Corp. | 6.45 Million USD | -144.35% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 2441.889% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 100.777% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 133.53% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -122.926% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -481.958% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 278.316% |
| AVAX Technologies, Inc. | -5.9 Million USD | 367.024% |
| Zenith Capital Corp. | 10.06 Thousand USD | -156527.583% |
| Genscript Biotech Corporation | -1.06 Billion USD | 101.485% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -7764.513% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -560.636% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -9481.847% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 86151.971% |
| Kadimastem Ltd | -253.1 Thousand USD | 6327.924% |
| Helix BioMedix, Inc. | -2.57 Million USD | 713.339% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 22.258% |
| BioStem Technologies, Inc. | 4.47 Million USD | -252.481% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -7732.391% |
| LadRx Corporation | -2.03 Million USD | 874.036% |
| Cell Source, Inc. | 9.23 Million USD | -70.744% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -2381.71% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -2381.71% |
| NovAccess Global Inc. | 2.17 Million USD | -623.583% |
| Affymax, Inc. | -5.59 Million USD | 381.633% |
| Itoco Inc. | 228.3 Thousand USD | -6804.36% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -11491.379% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -217.995% |
| Mobile Lads Corp. | 484.23 Thousand USD | -3155.258% |
| CytoDyn Inc. | 20.26 Million USD | 22.204% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 2436421.484% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 170173.605% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -104.555% |
| SYBLEU INC | 473.71 Thousand USD | -3227.535% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -253.667% |
| International Stem Cell Corporation | 2.59 Million USD | -508.61% |
| Bioxytran, Inc. | 1.89 Million USD | -730.106% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -25155.956% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -622.775% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -359.027% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -84.298% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -1940.235% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 1361.04% |
| Neutra Corp. | 52.18 Thousand USD | -30104.84% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 733.307% |
| PureTech Health plc | -167.19 Million USD | 109.428% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 6536.294% |
| IXICO plc | -4.44 Million USD | 454.656% |
| IntelGenx Technologies Corp. | 13.21 Million USD | -19.245% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 71.262% |
| CSL Limited | 10.52 Billion USD | 99.85% |
| Cellectis S.A. | -43.81 Million USD | 135.973% |